MacInnis Maureen J., Sr VP & Chief HR Officer, subtracted 15,000 shares of DENTSPLY SIRONA Inc. (XRAY) from its portfolio at the rate of $56.06 per share valuing $840,900 on Jun 10. The insider left behind 10,360 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of DENTSPLY SIRONA Inc. (XRAY) was $56.77. Currently, the 1st Resistance Point for this stock is $57.38, with a 2nd Resistance Point sitting at $57.99. Meanwhile, this company’s stock has a 1st Support Level at $56.39 and a 2nd Support Level at $56.00. DENTSPLY SIRONA Inc. (XRAY) stock has lost -$1.55, or -2.66%, in the past five days. In the last full month, these shares have lost -$0.50, or -0.87%. In the past three months, this stock’s price has risen by $6.28, or 12.44%. This year-to-date, DENTSPLY SIRONA Inc. (XRAY) shares have gained $19.56, or 52.57%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For DENTSPLY SIRONA Inc. (XRAY) stock, 40% of short-term indicators suggest that these shares are a “ Hold .” Meanwhile, 25% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 67% of long-term indicators suggest that this stock is a “ Buy .”
With 233,978 K shares outstanding, this company currently has a market capitalization of $13,282,931K. DENTSPLY SIRONA Inc. (XRAY) generates $3,986 M in annual sales, amounting to annual net income of -$1,011,000 K. This stock has generated a 1-Year Total Return of 26.44%, a 3-Year Total Return of -9.83%, and a 5-year Total Return of 21.77%. This stock’s 5-Year Dividend Growth is 40.00%, with its most recent dividend valued at $0.087 per share on 06/27/19. Its Annual Dividend Yield is 0.61%, and its Annual Dividend Rate is 0.35.
In the most recently-reported fiscal quarter, which ended in Mar-19, DENTSPLY SIRONA Inc. (XRAY) reported earnings of $0.49 per share. Wall Street analysts, on average, were expecting the company to report earnings of $0.39 per share, representing a 0.1 difference and 26.19% surprise. In the previous quarter ending in Dec-18, the reported earnings of $0.58 represented a 0.04 difference from the consensus estimate calling for $0.54 per share, which was a 8.01% surprise.
For the current fiscal quarter, which is set to end in 06/2019, the average earnings estimate is $0.62 per share. This estimate came from a total of 7 Wall Street Analysts. Of those market experts, the high estimate was $0.66 and the low estimate was $0.57. In the year-ago quarter, DENTSPLY SIRONA Inc. (XRAY) generated per-share earnings of $0.60. If the analysts are correct about the current quarter’s earnings, the growth will be +3.33% .
Turning our focus now to insider trading activity, there have been 26 purchases (286,275 shares in total) and 16 sale (208,122 shares in total) in the last 3 months. In the last 6 months, there have been 60 insider buys amounting to 346,539 shares and 29 insider sales amounting to 222,879 shares. In the past full year, 125 insider purchases were made (involving 387,348 shares) and 35 insider sell-offs equivalent to 247,024 shares.
Moving onto liquidity, DENTSPLY SIRONA Inc. (XRAY) has a Current Ratio of 1.86, a Quick Ratio of 1.27 and a Cash Ratio of 0.33. Looking at this company’s capital structure, its Total Debt to Total Equity is 32.36, its Total Debt to Total Capital is 24.45, and its Total Debt to Total Assets is now 19.08. Looking even further ahead into the future, its Long-Term Debt to Equity is 30.56 and its Long-Term Debt to Total Capital is 23.09.